Partnership: Pollen Health and Helius Medical Technologies

More posts

The US team at is pleased to have been appointed as a partner with Helius Medical Technologies.  Pollen is recognized as a leading medical communications agency with expertise in scientific storytelling and customized solutions for pharmaceutical and biotechnology companies. In this assignment, Pollen will concentrate on publication planning that supports scientific messages to help HCPs treat neurological symptoms caused by disease or trauma. A key area of focus will be differences in brain activity after electrical energy is delivered to the tongue through the Portable Neuromodulation Stimulator (PoNS) device.

Helius had its beginnings in the early 1990s in a lab at the University of Wisconsin-Madison. Now, Helius is a publicly traded company on the Toronto Stock Exchange in Canada and the OTCQB in the United States. Helius partners with top organizations to pioneer unique, noninvasive platform technologies to help meet the high unmet need of treating neurological symptoms of disease or trauma.

For additional information about Helius and their research initiatives, visit

Sorry, but comments are now closed.